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In a number of microbial pathogens that undergoes antigenic variation to evade the host’s
immune attack, genes encoding surface antigens are located at subtelomeric loci, and
recent studies have revealed that telomere components play important roles in regulation
of surface antigen expression in several of these pathogens, indicating that telomeres play
critical roles in microbial pathogen virulence regulation. Importantly, although telomere
protein components and their functions are largely conserved from protozoa to mammals,
telomere protein homologs in microbial pathogens and humans have low sequence homol-
ogy. Therefore, pathogen telomere components are potential drug targets for therapeutic
approaches because ﬁrst, most telomere proteins are essential for pathogens’ survival,
and second, disruption of pathogens’ antigenic variation mechanism would facilitate host’s
immune system to clear the infection.
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INTRODUCTION
Telomeres are nucleoprotein complexes located at the ends of lin-
ear chromosomes. Inmost eukaryotic cells, telomereDNAconsists
of simple repetitiveTG-rich sequences and ismaintainedby telom-
erase, a ribonucleoprotein that contains both a catalytic protein
subunit and an RNA component providing the template for de
novo telomere DNA synthesis (Greider and Blackburn, 1987).
A number of proteins have been identiﬁed that speciﬁcally
associate with the telomere DNA. In mammalian cells, the core
telomere protein complex termed “Shelterin” (de Lange, 2005)
contains two duplex TTAGGG repeat binding factors, TRF1 and
TRF2 (Chong et al., 1995; Bilaud et al., 1997; Broccoli et al., 1997),
a single-stranded telomere DNA binding protein, POT1 (Bau-
mann and Cech, 2001), and RAP1 (Li et al., 2000), TIN2 (Kim
et al., 1999), and TPP1 (Houghtaling et al., 2004; Liu et al., 2004;
Ye et al., 2004) that interact with TRFs or POT1. In addition, a
trimeric CST complex containing CTC1, STN1, and TEN1 has
also been identiﬁed to bind the single-stranded telomere DNA
(Miyake et al., 2009; Wan et al., 2009). Fission yeast has a very
similar telomere protein complex (Miyoshi et al., 2008), andmany
telomere protein homologs have been identiﬁed in budding yeast,
too (Lewis andWuttke, 2012). Recent studies have led to the iden-
tiﬁcation of TRF (Li et al., 2005) and RAP1 (Yang et al., 2009)
homologs in Trypanosoma brucei, a protozoan parasite belongs
to the kinetoplastids group, suggesting that the telomere complex
is largely conserved from protozoan to mammalian cells. Telom-
eres, together with their associated protein components, form a
specialized structure so that the natural chromosome ends are
properly protected (Stewart et al., 2011), while maintenance of a
stable length of telomere DNA provides adequate docking sites for
telomere binding proteins. Therefore, telomeres are essential for
genome stability and sustained cell proliferation.
Although telomeres are predominantly maintained by telom-
erase in most eukaryotes, DNA homologous recombination can
also serve as an important means for telomere maintenance
(McEachern and Haber, 2006; Nabetani and Ishikawa, 2011).
In addition, subtelomeric DNA recombination appears to be a
major factor for genome plasticity, which may help to diversify
the sequences of subtelomeric genes (Corcoran et al., 1988; Pologe
and Ravetch, 1988; De Bruin et al., 1994; Louis, 1995). For several
microbial pathogens whose virulence genes are located next to
telomeres, this can also be an important pathogenesis mechanism
to enhance their virulence (see below).
A telomere position effect (TPE) phenomenon has been
observed in a number of organisms, where the expression of genes
located at subtelomeres is suppressed by the nearby telomere chro-
matin structure (Gottschling et al., 1990; Baur et al., 2001; Koering
et al., 2002; Park et al., 2002; Pedram et al., 2006). TPE is well
studied in S. cerevisiae, where ScRap1 binds the duplex telomere
DNA (Longtine et al., 1989). Both ScRap1 and yKu (a heterodimer
complex that binds DNA ends in a sequence-independent man-
ner; Riha et al., 2006) can recruit the Sir4 silencer to the telomere,
and ScRap1 can also recruit Sir3 (Moretti et al., 1994; Martin et al.,
1999;Moretti and Shore, 2001; Luo et al., 2002). Together, Sir3 and
Sir4 recruit Sir2 (Moazed et al., 1997; Strahl-Bolsinger et al., 1997;
Buchberger et al., 2008; Martino et al., 2009), which is an NAD+-
dependent histone deacetylase (Tanny et al., 1999; Landry et al.,
2000) and can remove the acetyl group from histone H3 at K9
and K14 residues and from histone H4K16 (Imai et al., 2000). Sir2
activity and the interaction between Sir3/4 and histone tails are
necessary for establishing and propagating of the heterochromatic
structure from telomere to chromosome internal regions (Hoppe
et al., 2002). Similarly, TPE in human cells appears to be mediated
by the heterochromatic chromatin structure, as treatment with
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Trichostatin A, an inhibitor of class I and II histone deacetylases,
led to decreased TPE (Koering et al., 2002).
ANTIGENIC VARIATION AND PHENOTYPIC SWITCH IN
MICROBIAL PATHOGENS
Many microbial pathogens that infect mammals have adopted
antigenic variation to avoid eradication by the host immune sys-
tem so that they can maintain persistent infections and enhance
the chances of being transmitted to new hosts. Antigenic variation
is the phenomenon that a pathogen changes its surface antigen
presented to the host immune system regularly and much more
frequently than spontaneous gene mutation. The term of anti-
genic variation usually encompasses both phase variation and true
antigenic variation. In phase variation (such as phenotypic switch-
ing), the expression of an individual antigen switches between
“on” or “off” states. Multiple genes from the same gene family
can be expressed at the same time, and each gene’s expression
state is relatively independent to that of other genes in the same
family. Phenotypic switching can contribute to the virulence of
the pathogen because expressing different types or various num-
ber of surface molecules may enhance or weaken adhesion of the
pathogen to the host. In true antigenic variation, a certain antigen
switches among different forms. The antigen is usually expressed
in a mutually exclusive manner – a single gene from a multi-copy
gene family is expressed at any time. In general, both antigenic
variation and phenotypic switching can occur through two gen-
eral types of mechanisms: genetic and epigenetic (Deitsch et al.,
2009). A genetic event involves changes in DNA sequences of an
antigen encoding gene or its regulatory elements so that either
its expression level or its gene product is changed. An epigenetic
event only affects a gene expression level but does not change its
DNA sequences. However, recent studies suggest that epigenetic
changes such as chromatin remodeling may also inﬂuence genetic
events such asDNA recombination (Benetti et al., 2007; Bisht et al.,
2008). Common mechanisms of antigenic variation have evolved
in different pathogens, including bacteria, fungi, and parasites,
possibly due to similar selection pressure exerted from the mam-
malian immune responses. However, in this chapter, we will focus
on those mechanisms that are inﬂuenced or likely to be affected
by the telomere structure.
TPE PARTICIPATES IN THE REGULATION OF EPA
EXPRESSION IN C. glabrata
Candida glabrata is part of the normal human mucosal ﬂora
and usually commensal, but it can cause opportunistic mucosal
and bloodstream infections in immunocompromised individuals.
During infection, binding of the pathogen to host cell proteins or
microbial competitors would help to reduce the chance of clear-
ance by the host. Therefore, the adherence of C. glabrata to host
cells has been proposed to play an important role in its virulence
(Kaur et al., 2005).
When cultured human epithelial cells are used, 95% of in vitro
C. glabrata adherence depends on an adhesin molecule that binds
the host N-acetyl lactosamine-containing glycoconjugates (Cas-
tano et al., 2005) and is encoded by the EPA1 gene (Kapteyn et al.,
1999), which belongs to the EPA gene family. So far, a total of
23 putative EPA genes and pseudogenes have been identiﬁed in
C. glabrata strain BG2 based on their sequence similarity (Kaur
et al., 2005). Seven EPA genes encode full-length GPI-anchored
proteins, among which Epa1 is a lectin (Cormack et al., 1999),
Epa6 and Epa7 are conﬁrmed to be adhesins (Castano et al., 2005),
and Epa2 and Epa3 are predicted to be cell wall proteins (De Las
Penas et al., 2003). All seven EPA genes located at subtelomeric
regions (Figure 1; De Las Penas et al., 2003; Castano et al., 2005;
Iraqui et al., 2005).
Normally, only EPA1 gene is active, while EPA2–7 genes are
silenced by TPE, which depends on telomere protein Rap1. Dele-
tion of the C-terminal 28 amino acids of Rap1 led to derepression
of EPA4–7 and sometimes also EPA2 and EPA3 (De Las Penas
et al., 2003). Silencing of subtelomeric EPA genes also depends on
Sir proteins (De Las Penas et al., 2003; Castano et al., 2005). Dele-
tion of SIR3 led to hyper expression of EPA1 and derepression of
EPA2–7, although the derepression of EPA2, EPA3, and EPA4/5 is
mild. Deletion of SIR4 also led to derepression of EPA6. In the
case of deletion of SIR3, expression of EPA6 and EPA7 appears to
contribute to the hyper-adherent phenotype, indicating that TPE
can be directly involved in regulation of pathogen virulence (Cas-
tano et al., 2005). Interestingly, Epa6 expression is associated with
the ability of C. glabrata cells to form bioﬁlm on plastic surface
(Iraqui et al., 2005). Bioﬁlm formed by microbial pathogens can
increase infection probability and is of great clinical importance
because microorganisms adopting this life form is more tolerant
or resistant to host defense machinery and anti-microbial agents
than free cells.
This TPE regulated adhesin expression is well exploited by C.
glabrata to adapt to the host environment. C. glabrata is an nico-
tinic acid (NA or vitamin niacin) auxotroph, as it lost all the BNA
genes involved in the NA synthesis except BNA5 (Domergue et al.,
2005). When growing in urine, where NA is limited, the activity
of Sir2, an NAD+-dependent histone deacetylase, decreases corre-
spondingly since NA is the precursor of NAD+. As a consequence,
TPE level decreases, and EPA1, 6, and 7 genes are highly expressed
(Domergue et al., 2005). This effect can be reverted by adding
NA or a related compound nicotinamide (NAM). Most impor-
tantly, when using an established murine model of urinary track
infection, transurethrally inoculated C. glabrata has an elevated
colonization frequency in bladder and kidney, which is dependent
on EPA1, 6, and 7 gene expression, and mice fed with high-NA
diet are no longer susceptible to high rate of colonization of C.
glabrata (Domergue et al., 2005). Therefore, in C. glabrata, TPE
plays an important role in regulation of virulence gene expression.
Sir2-MEDIATED TPE PLAYS AN ESSENTIAL ROLE IN
MANOALLELIC EXPRESSION OF var GENES IN
P. falciparum
Plasmodium falciparum is a protozoan parasite in theApicomplexa
phylum that causes the most severe form of malaria, which is a
debilitating and sometimes fatal disease mostly found in tropical
and subtropical regions of the world. During P. falciparum infec-
tion in a human host, the parasite invades ﬁrst hepatocytes then
erythrocytes. Onemajor reason why it is very difﬁcult to eliminate
these parasites once an infection is established is that P. falciparum
undergoes antigenic variation at the erythrocyte stage (Dzikowski
and Deitsch, 2009). At this stage, P. falciparum cells produce
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FIGURE 1 | (A) EPA1–7 are located at subtelomeric loci in C. glabrata.
The positions of seven EPA genes at their respective chromosome end
loci are shown. EPA1 is furthest away from the telomere and is the only
one that is expressed normally, while EPA 2–7 are usually silenced by
TPE. Pink arrowheads, telomere repeats. (B)The telomere protein
complex in budding yeast. Rap1 is the duplex telomere DNA binding
factor, while Cdc13/Stn1/Ten1 binds to single-stranded telomere DNA.
Rap1 recruits Sir3 and Sir4, which in turn recruits Sir2. Sir3 and Sir4
can also interact with histones directly. Sir2’s deacetylase activity
maintains the hypoacetylated state of histones. Rap1 also recruits Rif1
and Rif2. Red stars, histone acetylation groups; green cylinders,
nucleosomes.
erythrocyte membrane protein 1 (PfEMP1), which is encoded by
var genes and is transported to the infected erythrocytemembrane
(Baruch et al., 1995; Smith et al., 1995; Su et al., 1995). Expression
of PfEMP1 on the infected cell surface allows the infected erythro-
cyte to adhere to the endotheliumof the post-capillary venules and
avoid circulation through the spleen, where the infected cells will
be destroyed (Baruch, 1999). Therefore, expression of PfEMP1
on host cell surface is critical for prolonged parasite infection.
However, PfEMP1 is also susceptible to host antibody recognition
and subsequent immune attack. As an important virulence mech-
anism, P. falciparum regularly switches the expressed PfEMP1,
therefore effectively evading the host immune attack (Roberts
et al., 1992).
There are ∼60 var genes in the P. falciparum genome (Gard-
ner et al., 2002). However, only one var gene is expressed at
any moment (Roberts et al., 1992). Based on its upstream reg-
ulatory elements, var genes can be classiﬁed into three groups
(Figure 2; Kraemer and Smith, 2003; Lavstsen et al., 2003). Those
with UpsA and transcribed toward the telomere and those with
UpsB and transcribed away from the telomere are located at sub-
telomeric loci (Figure 2A), while the ones with UpsC are located
at chromosome internal loci (Figure 2B; Voss et al., 2000; Gard-
ner et al., 2002; Kraemer and Smith, 2003; Lavstsen et al., 2003).
Monoallelic expression of var gene is regulated at multiple levels,
and telomeres appear to play an important role (Dzikowski and
Deitsch, 2009).
Telomere position effect in P. falciparum spreads ∼55 kb along
the chromosome from telomeres and was ﬁrst observed by target-
ing a reporter gene to the rep20 repeats located at the subtelomeric
regions (Figure 2A; Duraisingh et al., 2005). Rep20 is the most
telomere-distal telomere associated repetitive element (TARE)
and is usually adjacent to the subtelomeric var gene promoter.
TPE in P. falciparum depends on Sir2 (Duraisingh et al., 2005;
Freitas-Junior et al., 2005; Tonkin et al., 2009), which is both a
histone deacetylase and an ADP-ribosyltransferase (Merrick and
Duraisingh, 2007; Chakrabarty et al., 2008) and is localized at the
telomeres, where histones H4 acetylation is absent (Freitas-Junior
et al., 2005). By examining subnuclear localization of a number of
genetic markers along chromosome 2 by FISH, it is also inferred
that chromatin structure ismore condensed for telomere-proximal
regions than telomere-distal ones (Freitas-Junior et al., 2005). The
direct evidence of involving TPE in var gene regulation came
from the observation that deletion of PfSir2 led to a signiﬁcant
increase in transcription of a subset of var genes, particu-
larly the var genes with UpsA and at the subtelomere regions
(Duraisingh et al., 2005).
RAP1-MEDIATED SILENCING IS ESSENTIAL FOR
MONOALLELIC EXPRESSION OF VSG IN T. brucei
The kinetoplastids are a groupof ﬂagellated protozoa. Threemem-
bers of kinetoplastids are of great clinical importance because
they cause human diseases: Trypanosoma brucei causes human
African trypanosomiasis or sleeping sickness, Trypanosoma cruzi
causes South America trypanosomiasis or Chagas disease, and
several Leishmania species cause leishmaniasis. Of these three try-
panosomatids (the kinetoplastid organisms that only have a single
ﬂagellum), only T. brucei undergoes antigenic variation, which is
an important mechanism of its pathogenesis and one of its most
interesting biological aspects (Barry and McCulloch, 2001).
Trypanosoma brucei is transmitted between mammalian hosts
by an insect vector, tsetse (Glossina spp.).While inside themid-gut
of a tsetse ﬂy, T. brucei cells are in the non-virulent proliferative
stage, procyclic form (PF), and several procyclic acidic repeti-
tive proteins (PARPs, or procyclins) are expressed on its surface.
After T. brucei cells migrate into the salivary gland of the tsetse
ﬂy, they differentiate into the metacyclic form, stop proliferating,
and acquire virulence. When a tsetse ﬂy takes a blood meal, T.
brucei cells can be injected into a mammalian host. They stay in
the bloodstream or extracellular spaces in the host and quickly
differentiate into bloodstream form (BF). The slender BF is prolif-
erative, while the stumpy form is quiescent and non-proliferative.
The metacyclic form and BF cells express variant surface gly-
coproteins (VSGs) as their major surface glycoprotein (Mehlert
et al., 1998). When a tsetse ﬂy bites the infected mammalian host,
stumpy bloodstream form T. brucei cells taken into the midgut of
a tsetse can quickly differentiate into the PF, ending the life cycle
(Matthews, 2005).
Trypanosoma brucei is exposed to the host’s immune system
and is vulnerable to both the innate (inﬂammations, comple-
ments, etc.) and adaptive immune responses (antibody, killer
T cells, etc.). However, T. brucei has evolved a sophisticated
antigenic variation mechanism and regularly switches its surface
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FIGURE 2 | (A)The organization of subtelomere elements in P. falciparum.
Immediately internal to the telomere tract are six telomere-associated repeat
elements (TAREs 1–6), with the largest one, rep20, located furthest away
from the telomere repeats. One or two var genes are usually found
immediately upstream of rep20, followed by the riﬁn, stevor, and Pf60 gene
families. Depending on the upstream ﬂanking sequences, three classes of var
genes have been identiﬁed. The ones with associated UpsB and UpsA are
located at subtelomeric regions and transcribed in opposite directions as
drawn, while the ones with associated UpsC are located as gene arrays
in chromosome-internal loci (B). Little is known about the telomere
proteins in Plasmodium, except that Sir2 and Orc1 is located at the telomere
vicinity (Mancio-Silva et al., 2008), and HP1 is associated with subtelomeric
TAREs (Perez-Toledo et al., 2009), which are shown in the bottom diagram
in (A).
VSG coat, thus effectively evading the host’s immune response
(Barry and McCulloch, 2001).
Antigenic variation inT. brucei has two essential aspects: switch
to express a different VSG gene (VSG switching) and monoallelic
expression of VSG. Although there are >1,500 VSG genes and
pseudogenes in the T. brucei genome (Berriman et al., 2005), only
one type of VSG is expressed at any time. After a new VSG gene
is turned on, it is essential to turn off the previously active VSG
so that the old surface antigen is no longer presented to the host
immune system. In addition, expressing only one VSG gene at a
time would allow the VSG gene pool to be used for a maximum
period of time, enabling a persistent infection. Therefore, both
VSG switching and monoallelic expression of VSG are critical for
antigenic variation and have been the focus of intensive research
for several decades.
There are 11 pairs of megabase chromosomes (0.9–5.7 Mb),
several intermediate chromosomes (300–900 kb), and∼100 copies
of minichromosomes (50–100 kb) in T. brucei genome (Melville
et al., 2000;Alsford et al., 2001; Berrimanet al., 2005). Themajority
of VSG genes are found in long tandem arrays of repeated genes at
subtelomeric locations on megabase chromosomes (Figure 3C).
Approximately 200 copies of VSG genes are found immediately
upstream of telomeres of the minichromosomes, which carry
besides theVSG genes, only repetitive sequences, including 177 bp
repeats in the chromosome internal region and telomere repeats
at the chromosome ends (Figure 3D; Alsford et al., 2001). The
VSG genes in subtelomeric gene arrays and on minichromo-
some are often referred to as basic VSG copies because they are
transcriptional silent. The rest of VSGs are found in VSG expres-
sion sites. In BF T. brucei cells, VSGs are expressed exclusively
from bloodstream form VSG expression sites (B-ESs) which are
RNA polymerase I (RNAP I)-transcribed, polycistronic transcrip-
tion units located at subtelomere loci (Figure 3A; de Lange and
Borst, 1982; Gunzl et al., 2003). VSG is the last gene in any B-
ES and is usually within 1.5 kb from the telomere repeats, while
the promoter is often 40–60 kb upstream of the VSG (Hertz-
Fowler et al., 2008). In contrast, at the metacyclic stage, VSGs are
expressed from metacyclic VSG expression sites (M-ESs), which
are monocistronic transcription units located at the subtelom-
eric regions (Figure 3B), with the promoter located only ∼5 kb
from the telomere (Lenardo et al., 1984; Cornelissen et al., 1985).
Although the M-ESs have much simpler organizations than the
B-ESs, much less is understood about metacyclic than blood-
stream VSG expression regulation. T. brucei has multiple B-ESs
(e.g., Lister 427 has 15 different B-ESs), usually carrying different
VSGs, but all B-ESs have very similar genomic organization with
∼90% sequence identity (Hertz-Fowler et al., 2008). Earlier stud-
ies focused on B-ES promoters also showed that they are almost
always identical (Zomerdijk et al., 1990, 1991; Pham et al., 1996).
Therefore, how T. brucei manages to fully express only one B-
ES and VSG had been a great puzzle for more than a couple of
decades.
A number of studies in the last decade have shown that VSG
expression is regulated at multiple levels. First, transcription elon-
gation from B-ES promoter appears to be regulated. Silent B-ES
promoters are actually mildly active (Vanhamme et al., 2000), but
transcription elongation is quickly attenuated after a few kilobases,
effectively stopping transcription long before the VSG genes. Sec-
ond, chromatin structure of the active B-ES is very different from
the silent B-ESs. The active B-ES has very few nucleosomes while
silent ESs are packed with nucleosomes (Figueiredo and Cross,
2010; Stanne and Rudenko, 2010). Chromatin remodeling also
plays an important role in regulating theB-ES expression: Deletion
of the histone H3K79 methyltransferase TbDot1b led to a 10-fold
increase in transcription throughout the silent B-ESs (Janzen et al.,
2006). Additional chromatin remodelers have been shown to affect
B-ES promoter but not downstream VSG expression (Figure 3E):
Depletion of a Swi/Snf homolog, TbISWI, led to an elevated tran-
scription from the silent B-ES promoters (Hughes et al., 2007;
Stanne et al., 2011); DAC3, a histone deacetylase homologs, is
required for B-ES promoter silencing (Wang et al., 2010); and
depletion of TbSpt16, a subunit of the FACT chromatin remod-
eling complex, also led to an ∼20-fold increase in silent B-ES
promoter transcription (Denninger et al., 2010). Third, ever since
the discovery that VSGs are exclusively expressed from subtelom-
eric regions (de Lange and Borst, 1982), it has been proposed that
telomeres may play an important role in VSG expression regula-
tion (Dreesen et al., 2007). This hypothesis was supported by the
fact that TPE has been observed in T. brucei (Horn and Cross,
1997a; Glover and Horn, 2006).
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FIGURE 3 | Distribution ofVSG genes inT. brucei genome. (A) In a
bloodstream form VSG expression site (B-ES), the VSG gene is the last
one in the large polycistronic transcription unit and is located within
2 kb of the telomere repeats. A stretch of 70 bp repeats with various
length is located upstream of the VSG gene followed by a number of ES
associated genes (ESAGs). (B)The metacyclic VSG expression site
(M-ES) is a monocistronic transcription unit also located at subtelomeric
region. (C) Most VSG genes and pseudogenes (and some ESAG genes)
are found in gene arrays located at subtelomeric regions on megabase
chromosomes. Short stretches of 70 bp repeats are found upstream
of each gene. (D) On minichromosomes, single VSG genes and upstream
70 bp repeats are also found at subtelomeric regions. (E)The telomere
protein, TbRAP1, has been shown to play an important role in silencing
subtelomeric VSG genes. TbTRF andTbRAP1 are two knownT. brucei
telomere proteins. TbRAP1-mediated silencing is stronger (thick line) at
telomere-proximal VSG locus and weaker (thin line) at telomere-distal ES
promoter region. Several factors important for ES promoter silencing are
also shown.
Although the earlier studies provided promising evidence for
TPE, direct evidence linking TPE and VSG silencing was lacking
for a long time. In addition, although the T. brucei Sir2 homolog
plays an essential role in TPE at reporter marked telomeres with-
out native B-ESs, its deletion does not affect VSG silencing at all
(Alsford et al., 2007). Furthermore, Glover et al. (2007) was able
to target an I-Sce I digestion site together with a neo reporter gene
downstream of the VSG gene and immediately upstream of the
telomere in a telomerase null background. Induction of ectopic
I-SceI expression led to immediate cleavage and loss of themarked
telomere. Within 9 h, degradation of the reporter gene and the
subtelomeric VSG gene was also observed. Although a mild dere-
pression of the reporter gene was observed shortly before it was
degraded, the VSG gene was not derepressed at all (Glover et al.,
2007). These observations raised a great deal of doubts whether
telomeres are indeed necessary for proper VSG silencing.
It was difﬁcult to examine the roles of the telomere in antigenic
variation directly without identifying any telomere speciﬁc pro-
teins. Earlier attempts to identify telomere DNA binding factors in
T. brucei using biochemical approaches led to the identiﬁcation of
a couple of telomereDNAbinding activities without identiﬁcation
of the responsible proteins (Eid and Sollner-Webb, 1995, 1997).
The ﬁrst T. brucei Shelterin homolog, TbTRF, was identiﬁed
using an in silico approach (Li et al., 2005), and a yeast 2-hybrid
screen using TbTRF as bait led to the identiﬁcation of T. brucei
RAP1 (Yang et al., 2009), another integral component of theT. bru-
cei telomere complex (Figure 3E).When TbRAP1 was depleted by
RNAi (Shi et al., 2000), a derepression of silent B-ES-linked VSGs
can be detected (Yang et al., 2009). Using quantitative RT-PCR
analysis, it was shown that all B-ES-linked silent VSGs had an ele-
vated expression level upon depletion of TbRAP1, although the
level of derepression varies among different VSGs, ranging from
8- to 56-fold. Subsequently, it was conﬁrmed by IF that multi-
ple VSGs are expressed simultaneously in individual cells on cell
surface (Yang et al., 2009). Importantly, the TbRAP1-mediated
silencing is position dependent. First, only subtelomeric B-ES-
linkedVSGs were affected. Genes located in chromosome internal
regions including RNAP I transcribed rDNA and RNAP II tran-
scribed telomerase protein gene, a ribosomal protein gene, and
a glycolytic protein gene were not affected. Second, within an
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individual B-ES, the telomere-adjacent VSG gene is derepressed
at the highest level, a VSG pseudogene located 7–20 kb away
from the telomere is derepressed at an intermediate level, and a
reporter gene targeted immediately downstream of the B-ES pro-
moter located 40–60 kb away from the telomere is derepressed
at the lowest level (Figure 3E). It is therefore convinced that the
TbRAP1-mediated silencing originates from the telomere, demon-
strating for the ﬁrst time that the telomere structure indeed plays
an essential role in VSG expression regulation (Yang et al., 2009).
However, the involvement of telomere inVSG expression regu-
lation does not necessarily exclude other mechanisms mentioned
above. In fact, TbRAP1-mediated silencing appears to block the
elongation of the basal level transcription from the silent B-ES
promoters, because in TbRAP1 deﬁcient cells, derepressed VSGs
are expressed at a level that is still ∼100 fold lower than when
the same VSG is in a fully active B-ES (Yang et al., 2009). There-
fore, the observed quick attenuation of transcription elongation
along silent B-ESs may well be the combined effect of a basal level
transcription initiated from silent B-ES promoters and a TbRAP1-
mediated TPE. The fact that derepressedVSGs are not expressed at
its fullest potential also suggests that B-ES promoters are regulated
by additional factors other than TPE. This is consistent with the
observations that a number of chromatin remodeling factors are
involved in B-ES promoter regulation as mentioned above.
Recent studies have made great contributions to our under-
standing of how VSG expression is silenced. However, how is
allelic-exclusive expression of VSG achieved is not fully under-
stood. It has been proposed that sufﬁcient amount of RNAP I
machinery, which is responsible for high level VSG transcription,
may be accessible to only one B-ES,which would effectively ensure
its monoallelic expression (Horn and McCulloch, 2010). In an IF
analysis, Navarro and Gull (2001) found that in BF T. brucei cells,
transcriptionally active RNAP I forms a small nuclear focus in
addition to the large focus inside the nucleolus, where it tran-
scribes rRNA. In addition, only the active B-ES but not the silent
ones is co-localized with RNAP I in this ES body (ESB), which
only exists in BF but not PF cells (Navarro and Gull, 2001). It is
therefore hypothesized that ESB, enriched with RNAP I, can only
accommodate one B-ES,which would effectively limit the number
of active B-ES to one. In support of this view,when twodifferent B-
ESs were tagged with selective markers immediately downstream
of their respective promoters and forced to be active simultane-
ously, the two B-ESs appear to switch back and forth rapidly and
locate next to each other in the nucleus, presumably competing
for available RNAP I at ESB (Chaves et al., 1999).
TELOMERE LENGTH AFFECTS VSG SWITCHING FREQUENCY
AND MECHANISM IN T. brucei
VSG switching can occur through several different pathways
(Figure 4; Barry and McCulloch, 2001). In the so-called in situ
switch, a silent B-ES promoter is turned fully active while the
originally active B-ES promoter is turned off without any DNA
rearrangements. There are 15 B-ESs carrying distinctive VSGs in
the T. brucei Lister 427 cells, providing a small number of possible
in situ switch opportunities (Hertz-Fowler et al., 2008). However,
in situ VSG switching is usually a rare event, and VSG switching
involving DNA recombination events are much more prevalent
(Robinson et al., 1999). The large VSG gene pool, therefore,
provides essentially endless possibilities for VSG switching.
In gene conversion events, a silentVSG is copied into the active
B-ES while the originally active VSG is lost. In this event, the
donor can be any functional VSG gene in the genome. There is
almost always a stretch of 70 bp repeats upstream of a VSG gene,
in which homologous recombination can initiate as DNA double-
strand breaks (Boothroyd et al., 2009). In rare occasions, several
VSG donors have been identiﬁed in a single VSG switching event,
where each donor contributes only a fragment of the gene, gener-
ating a newmosaicVSG gene product (Marcello and Barry, 2007).
Such mechanism has been proposed to be useful in late stage of
persistent infection. More often, a silent B-ES is used as a donor
possibly because long stretch of 70 bp repeats (2 to >14 kb) and
telomere repeats (3–20 kb) ﬂank the VSG gene in any B-ES, and
efﬁcient homologous recombination can initiate from these sites.
In fact, all B-ESs have very similar genome organization and are
∼90% identical in sequences, so gene conversion event can initi-
ate at places upstream of 70 bp repeats and often a whole silent
B-ES can be copied to replace the active B-ES (Pays et al., 1983b;
Hertz-Fowler et al., 2008). Therefore, the terms of VSG gene con-
version and ES gene conversion are used to differentiate different
types of gene conversion events (Kim and Cross, 2010). In addi-
tion to gene conversion, reciprocal crossover event can occur in a
VSG switching (Rudenko et al., 1996). In this case, the crossover
usually occurs at the 70 bp repeats, and the silent and active VSGs
(often together with their respective downstream telomeres) sim-
ply trade places without deletion of large fragments of genetic
information. It is worth to note that in a crossover switching, the
originally silent VSG often comes from a silent B-ES, but it can
also be from a minichromosome subtelomere. Finally, more com-
plicated switching events involving loss of the active B-ES or VSG
associated with an in situ switch have also been observed (Kim and
Cross, 2011).
It has been shown that homologous DNA recombination
is important for VSG switching in T. brucei (McCulloch and
Barry, 1999). In homologous recombination, searching for DNA
sequence homology and subsequent strand-invasion is a key step,
at which RAD51 polymerizes around ssDNA to assemble a nucleo-
protein helical ﬁlament and,with the help of ATP, extends theDNA
structure and carries out the strand exchange process (Holloman,
2011). When ssDNA is coated with RPA (a single-strand-speciﬁc
DNA binding protein), it will not be accessible by RAD51 with-
out the help of a mediator, such as BRCA2 (Holloman, 2011). In
T. brucei, six RAD51 related proteins have been identiﬁed: RAD51,
DMC1, RAD51-3, RAD51-4, RAD51-5, and Rad51-6 (Proudfoot
and McCulloch, 2005). Among these, deletion of TbRAD51 and
TbRAD51-3 led to a decrease inVSG switching rate while deletion
of TbRAD51-5 did not have any effect, and deletion of TbBRCA2
also led to a similar decreased VSG switching rate (Hartley and
McCulloch, 2008). In addition, TbTOPO3α and TbRMI1, whose
homologs in mammalian cells form a so-called RTR complex with
The RecQ helicase BLM and suppress aberrant and inappropriate
homologous recombination, were recently shown to be involved
in regulation of VSG switching (Kim and Cross, 2010, 2011).
Apparently, homologous recombination is a major pathway for
VSG switching. However, exactly how VSG switching is regulated
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FIGURE 4 |VSG switching can occur through in situ switch, gene
conversion, or crossover.Top Middle, before switching, an active B-ES (long
red arrow), a silent B-ES (short blue arrow), a VSG gene at a minichromosome
subtelomere, and an array of VSG genes and pseudogenes on a megabase
chromosome are shown. In situ switch (top left) results from turning on (long
blue arrow) of the silent B-ES and turning off (short red arrow) of the active
B-ES simultaneously without any DNA rearrangements. In gene conversion, a
silent VSG gene is duplicated into the active B-ES, and the originally active
VSG gene is lost. The VSG donor can come from a silent B-ES (bottom left), a
minichromosome subtelomere (bottom middle), or a VSG gene array
(bottom-right). In VSG cross-over (top right), the active VSG and a silent VSG
(most often from a silent B-ES) exchange their loci reciprocally, resulting in a
new VSG gene in the active B-ES without losing any genetic information. The
cross-over site is often found within the 70 bp repeats upstream of the VSG
genes, although it can locate more upstream, and all B-ESs have high
sequence homology.
is less clear. Several recent studies now indicate that the telomere
structure can inﬂuence VSG switching greatly.
It has been shown that the active VSG-marked telomere is less
stable than the silent telomeres (Bernards et al., 1983; Pays et al.,
1983a; vanderPloeg et al., 1984;Myler et al., 1988;Horn andCross,
1997b). Rapidly shortened active telomere arises frequently, which
is quite similar to the TRD observed in yeast cells carrying abnor-
mally long telomeres (Li and Lustig, 1996). Presumably the active
transcription of the telomere is a major cause for the brittle active
telomere (Rudenko andVan der Ploeg, 1989).With the presence of
telomerase, shortened telomeres are elongated quickly (Horn et al.,
2000). With frequent truncation and elongation, telomere length
at the active chromosome end is often much more heterogeneous
than those at silent telomeres (Bernards et al., 1983). However, in
the absence of telomerase, the truncated active telomere remains
short, allowing the isolation of clones baring extremely short active
telomere in a relatively short culturing period (Dreesen and Cross,
2006). Interestingly, when such telomerase negative clones were
obtained that carry extremely short active telomere, these clones
tend to switch to express a new VSG (Dreesen and Cross, 2006).
This observation led to the hypothesis that shorter telomeres may
cause higherVSG switching rate (Dreesen et al., 2007). It is specu-
lated that all active telomeres are prone to large telomere fragment
deletions due to its active transcription state, but shorter telomeres
aremore likely to have a deletion landed in the subtelomeric region
and to cause damage in the active VSG gene, which will force the
parasite to go through VSG switching. Introducing a break at the
I-SceI site targeted immediately upstream of the active VSG gene
led to a 250-fold increase in VSG switching frequency, conﬁrming
part of this theory that damage to the active VSG gene will force
the parasite to switch (Boothroyd et al., 2009).
Importantly, a recent study showed that cells carrying short
active telomeres (∼1.5 kb) has an∼6.3-fold higherVSG switching
frequency than cells carrying long telomeres (>10 kb; Hovel-
Miner et al., 2012). In addition, cells with short active telomere also
have more gene conversion and much fewer telomere crossover
events as VSG switching mechanism (Hovel-Miner et al., 2012).
Therefore, telomere length indeed affects subtelomeric VSG
switching. At least two Shelterin homologs have been identiﬁed in
T. brucei (Li et al., 2005; Yang et al., 2009), which enabled further
investigation of the telomere structure in VSG switching regu-
lation. It is speculated that disruption of the heterochromatic
telomere structure, especially in the case of depletion of TbRAP1
(Yang et al., 2009), may also lead to higher VSG switching rate,
similar to what was observed in S. pombe (Bisht et al., 2008).
DOES TELOMERE AFFECT SWITCHING OF
SUBTELOMERE-LOCATED SURFACE ANTIGEN
IN P. carinii AND B. burgdorferi?
Pneumocystis carinii is a fungus that solely dwells in the lung tis-
sue of mammals. Normally, P. carinii infection does not cause
any symptom, but in immunocompromised individuals it can
cause pneumonia. The complete life cycle of P. carinii is still
not very well deﬁned, mainly because of the lack of a continu-
ous cultivation system. However, it is obvious that P. carinii can
survive in the lower respiratory tract where strong and effective
defense systems normally work to eliminate invaders, and the
reason for persistent and effective P. carinii infection is that it
undergoes antigenic variation at a high frequency (Cushion and
Stringer, 2010).
The Major Surface Glycoprotein (MSG) is one of the major
surface molecules of P. carinii that is involved in antigenic varia-
tion (Stringer, 2005). MSG is encoded by the MSG gene family.
So far 73 MSG genes have been identiﬁed, all are located at the
subtelomeric loci (Figure 5; Keely and Stringer, 2009). There are
17 chromosomes in P. carinii (Hong et al., 1990), indicating that
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FIGURE 5 | Gene arrays at the ends of three Pneumocystis carinii
chromosomes. MSG genes (cyan colored arrows) are located closest to the
telomere and subtelomeric repetitive sequences. A single copy UCS is found
in the active MSG expression site immediately upstream of the MSG gene.
on average at least two MSG genes are at each telomere, which is
often the case in cloned terminal fragments from various chromo-
somes (Wada and Nakamura, 1996; Keely et al., 2005). Similar to
the situation in T. brucei, only one MSG gene is transcribed at any
time. Transcribed MSG messengers always contained an upstream
conserved sequence (UCS; Wada et al., 1995; Edman et al., 1996;
Wada andNakamura, 1996; Sunkin and Stringer, 1997), which has
only one copy in the P. carinii genome (Wada et al., 1995; Edman
et al., 1996), suggesting that MSG is transcribed from a speciﬁc
expression site marked with the unique UCS element. In addi-
tion, translation initiation codon on an MSG mRNA is located
in the sequence transcribed from the UCS (Wada et al., 1995;
Edman et al., 1996). Therefore, transcribing MSG from UCS-
containing expression site is essential for proper MSG translation.
Furthermore, the UCS encoded peptide contains a signal sequence
that targets the pre-MSG protein into the endoplasmic reticulum,
where it can be cleaved and glycosylated, then deposited on the cell
surface (Sunkin et al., 1998). Hence the UCS peptide is also essen-
tial for MSG function, although it is not present on MSG found
on the cell surface because it is likely removed in the endoplasmic
reticulum.
If P. carinii contains only one UCS-containing MSG expres-
sion site, how does it achieve antigenic variation? Computational
analysis of MSG gene sequences suggested that these genes com-
monly undergo recombination (Wada andNakamura, 1996; Keely
et al., 2005; Keely and Stringer, 2009), which is not unlike theVSG
switching in T. brucei. Similar to VSG, MSG is also the last tran-
scribed gene on the chromosome (Wada and Nakamura, 1996;
Keely et al., 2005). The proximity of MSG genes to telomeres
suggests that the MSG switching events might also be regulated
by the telomere structure, although this has not be investigated
at all.
In adifferentmicrobial pathogenBorrelia burgdorferi, the spiro-
chete that causes the Lyme disease, the gene encoding variant
surface antigen is found at a subtelomere region on a linear plas-
mid (Zhang et al., 1997). B. burgdorferi also undergoes antigenic
variation, and the lipoprotein VlsE is the variant surface pro-
tein (Schwan et al., 1991; Zhang et al., 1997; Zhang and Norris,
1998b; Steere et al., 2004; Norris, 2006). VlsE is encoded by the
vls gene family located on the linear plasmid lp28-1 (Figure 6).
Immediately next to the telomere is the active vlsE expression
site. More upstream is the silent vls gene cluster (Zhang et al.,
1997). Bacteria lost the lp28-1 exhibit an intermediate infectivity
phenotype where it is hard to establish a persistent infection in
the mouse model (Bankhead and Chaconas, 2007). Deletion of
vlsE and silent vls cassettes also led to reduced persistent infec-
tion, indicating that antigenic variation through vls switching is
an important virulence mechanism in B. burgdorferi (Zhang et al.,
1997; Purser and Norris, 2000; Labandeira-Rey and Skare, 2001;
Bankhead and Chaconas, 2007). The vlsE and the silent vls genes
are highly homologous at the sequence level, and most of the
sequence differences within the cassette regions are concentrated
in six variable regions, VR1–VR6 (Zhang and Norris, 1998a). Seg-
mental gene conversion between the silent cassettes and the vlsE
cassette region occurs as early as 4 days after infection inmice, and
appears to continue throughout the course of infection (Zhang
and Norris, 1998b). Because these recombination events appear to
involve random segments of any silent cassette and occur continu-
ously during infection, an almost unlimited number ofVlsE amino
acid sequence permutations are theoretically possible (Zhang and
Norris, 1998a). Apparently, vls switching is not so unlike the VSG
switching in T. brucei or MSG switching in P. carinii. However,
nothing is known about the telomere structure at the ends of lp28
or anyprotein(s) associatedwith it. Therefore, it is unclearwhether
the nearby telomere structure might exhibit any inﬂuence to vls
switching.
TELOMERE COMPONENTS AS POTENTIAL TARGETS OF
ANTI-PATHOGEN AGENTS
In this review, I have provided a detailed treatise of the telomere
region, the adjoining genes and sites, and the regulatory elements
andproteins in severalmicrobial pathogens that undergo antigenic
variation. As discussed, telomere forms a specialized heterochro-
matic structure that can inﬂuence the expression of genes located
nearby. It appears that several microbial pathogens have conve-
niently taken advantage of this TPE to regulate expression of
surface antigen-encoding gene families at subtelomeric regions.
Further studies of the telomere structure and telomere-speciﬁc
proteins in thesemicrobial pathogens should providemore insight
about the allelic exclusion expression of surface antigen genes.
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FIGURE 6 |The organization of vlsE and the array of silent vls genes on
lp28 linear plasmid of B. burgdorferi.The vls1 gene (moss colored arrow) is
expressed from the vlsE expression site next to the telomere (pink arrows).
The direct repeats (barred boxes) and the unique regions (green boxes)
ﬂanking the vls1 gene and the lipoprotein leader sequence (rouge box)
upstream of vls1 are marked. The silent array includes vls2–16 genes (various
colored arrows) going to the opposite direction from vls1 are located at the
internal region of the linear plasmid.
In addition, the subtelomeric region in many eukaryotic cells
appears to be a DNA recombination hot spot, presumably con-
tributing to gene diversity. This could be one of the reasons
why many gene families encoding virulence factors are located
at subtelomeric loci in microbial pathogens. One cannot help
to speculate that the intrinsic plastic nature of the subtelomeres
might facilitate antigenic variation. On the other hand, unchecked
homologous recombination could cause hazardous genome insta-
bility, and the telomere structure with telomere-speciﬁc proteins is
hypothesized to suppress subtelomeric recombination tomaintain
a relatively stable genome organization.
The essential functions of telomeres in maintaining genome
integrity are conserved for all eukaryotic cells, and homologs of
many telomere-speciﬁc proteins have been identiﬁed from pro-
tozoa to mammals. However, telomere homologs from mammals
and those from the above-mentioned microbial pathogens have
very low sequence homology. As the telomere components play
important functions in regulation of virulence in several micro-
bial pathogens, they are attractive drug targets for treatment of
diseases caused by these pathogens. For example, TbRAP1 and
hRAP1 has very limited sequence homology. It should be feasible
to identify or develop agents that speciﬁcally target TbRAP1 but
not hRAP1. These agents are expected to act as a double-edged
sword. First, TbRAP1 is essential for trypanosome cell growth
and dysfunctional TbRAP1 leads to cell growth arrest. Second,
TbRAP1 is essential for complete subtelomericVSG silencing, and
lack of TbRAP1 leads to expression of multiple VSG proteins on
trypanosome cell surface, which will facilitate the host immune
system to eliminate the parasite efﬁciently.
Because most microbial pathogens growmuch faster than their
mammalian host, they are also more susceptible to agents that
disrupt the telomere structure or cause telomere length attrition,
which is more detrimental to fast growing cells. Because T. brucei
has a 3′ single-stranded G-rich overhang at the end of the telom-
eres, compounds that target the G-quadruplex such as Imetelstat
would be a good choice to inhibit T. brucei growth preferen-
tially. Imetelstat is a lipid-conjugated oligonucleotide (previously
known as GRN163), with excellent tissue penetration, bioavail-
ability, and efﬁcacy that has been used to against a variety of
cancers (Dikmen et al., 2005; Herbert et al., 2005; Gellert et al.,
2006). Other small molecule inhibitors that interact with the
human telomeric DNA are available (Sun et al., 1997), but they
may not inhibit parasites other than T. brucei due to telomere
sequence dissimilarity. Another potential target would be telom-
erase that synthesize the telomere DNA in most eukaryotic cells.
Although knockout telomerase is not expected to cause imme-
diate deleterious effects in parasites such as T. brucei that carry
long telomeres, changing the telomere sequence by incorpora-
tion of mutations into the telomerase RNA template may lead
to more acute cell growth arrest due to disrupted binding of the
mutant telomere DNA by normal telomere binding proteins, such
as TRF.
We have just begun to understand the functions of telomeres in
antigenic variation. New telomere components are continuously
investigated for their potential roles in this important mechanism
of pathogenesis. As we gain more knowledge, we expect to iden-
tify more suitable telomere components as good anti-pathogen
targets.
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